You just read:

Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia

News provided by

Intra-Cellular Therapies, Inc.

Mar 02, 2011, 07:06 EST